Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Abstract: This paper focuses mainly on the time and space complexity computation of the Tower of Hanoi, this mathematical game or puzzle is a well-known problem for its exponential time consumption, ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

I’ve been a couples therapist for 30 years: Any of these 6 phrases is a red flag in relationships Mara Corday Dies: ‘Tarantula' Cult Film Star & ‘Playboy' Playmate Was 95 Multiple Police Officers ...

The results of a recent survey released Tuesday showed President Trump's actions are likely to make it harder for biotech companies like Recursion to raise capital. The company reported ...

A code previously working until duckdb 1.0.0 started erroring out in duckdb 1.1 by raising following error: import pandas as pd import duckdb get_data = lambda start ...

Abstract: Memoization is a computational technique for speeding up the complexity of computer algorithms. It stores the previously calculated results and invokes them later in the body of the ...

The merger is anticipated to bolster therapeutic discovery collaborations. Credit: Max Acronym/Shutterstock. Recursion has agreed to merge with Exscientia to create a global technology-enabled drug ...

Artificial intelligence (AI)-based drug developer Recursion said it has completed the fastest supercomputer to be wholly owned and operated by any pharmaceutical company worldwide, using technology ...